Annual CFI:
$260.06M+$270.29M(+2642.62%)Summary
- As of today, RXRX annual cash from investing is $260.06 million, with the most recent change of +$270.29 million (+2642.62%) on December 31, 2024.
- During the last 3 years, RXRX annual cash from investing has risen by +$531.80 million (+195.70%).
- RXRX annual cash from investing is now at all-time high.
Performance
RXRX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFI:
-$5.81M+$1.46M(+20.11%)Summary
- As of today, RXRX quarterly cash from investing is -$5.81 million, with the most recent change of +$1.46 million (+20.11%) on June 30, 2025.
- Over the past year, RXRX quarterly cash from investing has dropped by -$1.63 million (-38.88%).
- RXRX quarterly cash from investing is now -102.11% below its all-time high of $275.46 million, reached on December 31, 2024.
Performance
RXRX Quarterly Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$257.82M-$1.63M(-0.63%)Summary
- As of today, RXRX TTM cash from investing is $257.82 million, with the most recent change of -$1.63 million (-0.63%) on June 30, 2025.
- Over the past year, RXRX TTM cash from investing has increased by +$271.49 million (+1986.00%).
- RXRX TTM cash from investing is now -0.86% below its all-time high of $260.06 million, reached on December 31, 2024.
Performance
RXRX TTM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
RXRX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +2642.6% | -38.9% | +1986.0% |
| 3Y3 Years | +195.7% | -217.6% | +363.4% |
| 5Y5 Years | +6751.1% | -10000.0% | +6313.9% |
RXRX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +195.7% | -102.1% | +27.2% | -0.9% | +1541.5% |
| 5Y | 5-Year | at high | +195.7% | -102.1% | +97.0% | -0.9% | +194.9% |
| All-Time | All-Time | at high | +195.7% | -102.1% | +97.0% | -0.9% | +194.9% |
RXRX Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$5.81M(+20.1%) | $257.82M(-0.6%) |
| Mar 2025 | - | -$7.27M(-102.6%) | $259.44M(-0.2%) |
| Dec 2024 | $260.06M(+2642.6%) | $275.46M(+6138.1%) | $260.06M(+1554.1%) |
| Sep 2024 | - | -$4.56M(-9.1%) | -$17.89M(-30.8%) |
| Jun 2024 | - | -$4.18M(+37.1%) | -$13.67M(-18.4%) |
| Mar 2024 | - | -$6.65M(-167.4%) | -$11.54M(-12.8%) |
| Dec 2023 | -$10.23M(-105.3%) | -$2.49M(-617.0%) | -$10.23M(+34.9%) |
| Sep 2023 | - | -$347.00K(+83.1%) | -$15.72M(-141.8%) |
| Jun 2023 | - | -$2.05M(+61.6%) | $37.61M(-15.7%) |
| Mar 2023 | - | -$5.34M(+33.1%) | $44.60M(-76.9%) |
| Dec 2022 | $193.25M | -$7.98M(-115.1%) | $193.25M(+29.7%) |
| Sep 2022 | - | $52.98M(+972.6%) | $148.99M(+252.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $4.94M(-96.6%) | -$97.87M(+10.2%) |
| Mar 2022 | - | $143.30M(+374.3%) | -$109.02M(+59.9%) |
| Dec 2021 | -$271.74M(-3009.2%) | -$52.24M(+73.1%) | -$271.74M(-21.3%) |
| Sep 2021 | - | -$193.87M(-3020.9%) | -$224.09M(-566.0%) |
| Jun 2021 | - | -$6.21M(+68.0%) | -$33.65M(-22.5%) |
| Mar 2021 | - | -$19.42M(-322.9%) | -$27.47M(-214.3%) |
| Dec 2020 | -$8.74M(-123.5%) | - | - |
| Dec 2020 | - | -$4.59M(-34.0%) | -$8.74M(-110.7%) |
| Sep 2020 | - | -$3.43M(-8684.6%) | -$4.15M(-473.9%) |
| Jun 2020 | - | -$39.00K(+94.3%) | -$723.00K(-5.7%) |
| Mar 2020 | - | -$684.00K | -$684.00K |
| Dec 2019 | -$3.91M | - | - |
FAQ
- What is Recursion Pharmaceuticals, Inc. annual cash from investing?
- What is the all-time high annual cash from investing for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. annual cash from investing year-on-year change?
- What is Recursion Pharmaceuticals, Inc. quarterly cash from investing?
- What is the all-time high quarterly cash from investing for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?
- What is Recursion Pharmaceuticals, Inc. TTM cash from investing?
- What is the all-time high TTM cash from investing for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. TTM cash from investing year-on-year change?
What is Recursion Pharmaceuticals, Inc. annual cash from investing?
The current annual cash from investing of RXRX is $260.06M
What is the all-time high annual cash from investing for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high annual cash from investing is $260.06M
What is Recursion Pharmaceuticals, Inc. annual cash from investing year-on-year change?
Over the past year, RXRX annual cash from investing has changed by +$270.29M (+2642.62%)
What is Recursion Pharmaceuticals, Inc. quarterly cash from investing?
The current quarterly cash from investing of RXRX is -$5.81M
What is the all-time high quarterly cash from investing for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high quarterly cash from investing is $275.46M
What is Recursion Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?
Over the past year, RXRX quarterly cash from investing has changed by -$1.63M (-38.88%)
What is Recursion Pharmaceuticals, Inc. TTM cash from investing?
The current TTM cash from investing of RXRX is $257.82M
What is the all-time high TTM cash from investing for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high TTM cash from investing is $260.06M
What is Recursion Pharmaceuticals, Inc. TTM cash from investing year-on-year change?
Over the past year, RXRX TTM cash from investing has changed by +$271.49M (+1986.00%)